Remove Drug Development Remove Leadership Remove Mobile Health
article thumbnail

Small Language Models (SLMs) have the potential to revolutionise Healthcare AI in addition to LLMs

Lloyd Price

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value > [link] Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.

article thumbnail

Digital Health v HealthTech: What is the difference?

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. This includes telehealth, mobile health apps, and wearable devices.

article thumbnail

How Technology Can Help Us Achieve Health Equity

Healthcare IT Today

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.